UniProt ID | SUV91_HUMAN | |
---|---|---|
UniProt AC | O43463 | |
Protein Name | Histone-lysine N-methyltransferase SUV39H1 | |
Gene Name | SUV39H1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 412 | |
Subcellular Localization | Nucleus. Nucleus lamina. Nucleus, nucleoplasm. Chromosome, centromere. Associates with centromeric constitutive heterochromatin. | |
Protein Description | Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3 using monomethylated H3 'Lys-9' as substrate. Also weakly methylates histone H1 (in vitro). H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in heterochromatin regions, thereby playing a central role in the establishment of constitutive heterochromatin at pericentric and telomere regions. H3 'Lys-9' trimethylation is also required to direct DNA methylation at pericentric repeats. SUV39H1 is targeted to histone H3 via its interaction with RB1 and is involved in many processes, such as repression of MYOD1-stimulated differentiation, regulation of the control switch for exiting the cell cycle and entering differentiation, repression by the PML-RARA fusion protein, BMP-induced repression, repression of switch recombination to IgA and regulation of telomere length. Component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus. Recruited by the large PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1, contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation.. | |
Protein Sequence | MAENLKGCSVCCKSSWNQLQDLCRLAKLSCPALGISKRNLYDFEVEYLCDYKKIREQEYYLVKWRGYPDSESTWEPRQNLKCVRILKQFHKDLERELLRRHHRSKTPRHLDPSLANYLVQKAKQRRALRRWEQELNAKRSHLGRITVENEVDLDGPPRAFVYINEYRVGEGITLNQVAVGCECQDCLWAPTGGCCPGASLHKFAYNDQGQVRLRAGLPIYECNSRCRCGYDCPNRVVQKGIRYDLCIFRTDDGRGWGVRTLEKIRKNSFVMEYVGEIITSEEAERRGQIYDRQGATYLFDLDYVEDVYTVDAAYYGNISHFVNHSCDPNLQVYNVFIDNLDERLPRIAFFATRTIRAGEELTFDYNMQVDPVDMESTRMDSNFGLAGLPGSPKKRVRIECKCGTESCRKYLF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Ubiquitination | --MAENLKGCSVCCK --CCCCCCCCCEECC | 70.25 | 22505724 | |
13 | Ubiquitination | KGCSVCCKSSWNQLQ CCCCEECCCCHHHHH | 42.26 | 29967540 | |
37 | Ubiquitination | CPALGISKRNLYDFE CCCCCCCCCCCCEEE | 43.30 | - | |
48 | Ubiquitination | YDFEVEYLCDYKKIR CEEEEEEEECCHHHH | 0.83 | - | |
63 | Ubiquitination | EQEYYLVKWRGYPDS CCEEEEEEECCCCCC | 28.69 | 29967540 | |
70 | Phosphorylation | KWRGYPDSESTWEPR EECCCCCCCCCCCCC | 29.01 | - | |
74 | Ubiquitination | YPDSESTWEPRQNLK CCCCCCCCCCCCCHH | 23.91 | 29967540 | |
81 | Ubiquitination | WEPRQNLKCVRILKQ CCCCCCHHHHHHHHH | 37.93 | 29967540 | |
87 | Ubiquitination | LKCVRILKQFHKDLE HHHHHHHHHHHHHHH | 48.85 | 29967540 | |
91 | Ubiquitination | RILKQFHKDLERELL HHHHHHHHHHHHHHH | 66.36 | 29967540 | |
92 | Ubiquitination | ILKQFHKDLERELLR HHHHHHHHHHHHHHH | 45.23 | 29967540 | |
98 | Ubiquitination | KDLERELLRRHHRSK HHHHHHHHHHHHHCC | 3.76 | - | |
98 | Ubiquitination | KDLERELLRRHHRSK HHHHHHHHHHHHHCC | 3.76 | 29967540 | |
102 | Ubiquitination | RELLRRHHRSKTPRH HHHHHHHHHCCCCCC | 33.62 | 29967540 | |
104 | Phosphorylation | LLRRHHRSKTPRHLD HHHHHHHCCCCCCCC | 36.20 | 23898821 | |
105 | Methylation | LRRHHRSKTPRHLDP HHHHHHCCCCCCCCH | 63.61 | 126257621 | |
106 | Phosphorylation | RRHHRSKTPRHLDPS HHHHHCCCCCCCCHH | 27.14 | 23898821 | |
113 | Phosphorylation | TPRHLDPSLANYLVQ CCCCCCHHHHHHHHH | 39.52 | 23898821 | |
117 | Phosphorylation | LDPSLANYLVQKAKQ CCHHHHHHHHHHHHH | 11.57 | 23898821 | |
121 | Ubiquitination | LANYLVQKAKQRRAL HHHHHHHHHHHHHHH | 50.50 | 21906983 | |
123 | Ubiquitination | NYLVQKAKQRRALRR HHHHHHHHHHHHHHH | 51.91 | 22817900 | |
123 | Methylation | NYLVQKAKQRRALRR HHHHHHHHHHHHHHH | 51.91 | 126257623 | |
132 | Ubiquitination | RRALRRWEQELNAKR HHHHHHHHHHHHHCH | 32.16 | 21963094 | |
132 | Ubiquitination | RRALRRWEQELNAKR HHHHHHHHHHHHHCH | 32.16 | - | |
134 | Ubiquitination | ALRRWEQELNAKRSH HHHHHHHHHHHCHHC | 32.26 | 22817900 | |
134 | Ubiquitination | ALRRWEQELNAKRSH HHHHHHHHHHHCHHC | 32.26 | - | |
138 | Ubiquitination | WEQELNAKRSHLGRI HHHHHHHCHHCCCCE | 54.05 | 23000965 | |
146 | Phosphorylation | RSHLGRITVENEVDL HHCCCCEEEECEECC | 22.02 | - | |
149 | Ubiquitination | LGRITVENEVDLDGP CCCEEEECEECCCCC | 50.70 | 23000965 | |
162 | Phosphorylation | GPPRAFVYINEYRVG CCCCEEEEEEEEEEC | 7.50 | 29496907 | |
214 | Methylation | DQGQVRLRAGLPIYE CCCCEEEECCCCEEE | 18.95 | 30995317 | |
224 | Phosphorylation | LPIYECNSRCRCGYD CCEEEECCCCCCCCC | 44.40 | 20068231 | |
260 | Phosphorylation | GRGWGVRTLEKIRKN CCCCCHHCHHHHHCC | 36.54 | 29083192 | |
266 | Acetylation | RTLEKIRKNSFVMEY HCHHHHHCCCCHHHE | 61.49 | 18004385 | |
297 | Phosphorylation | YDRQGATYLFDLDYV CCCCCCEEEEECCCE | 12.58 | - | |
381 | Phosphorylation | MESTRMDSNFGLAGL HHHCCCCCCCCCCCC | 25.39 | 23927012 | |
391 | Phosphorylation | GLAGLPGSPKKRVRI CCCCCCCCCCCCEEE | 31.44 | 29255136 | |
402 | Phosphorylation | RVRIECKCGTESCRK CEEEEEECCCHHHHH | 14.25 | 32645325 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SUV91_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
266 | K | Acetylation |
| 18004385 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SUV91_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"SIRT1 regulates the histone methyl-transferase SUV39H1 duringheterochromatin formation."; Vaquero A., Scher M., Erdjument-Bromage H., Tempst P., Serrano L.,Reinberg D.; Nature 450:440-444(2007). Cited for: FUNCTION, CATALYTIC ACTIVITY, ACETYLATION AT LYS-266, MUTAGENESIS OFLYS-266, AND SUBCELLULAR LOCATION. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391, AND MASSSPECTROMETRY. |